Skip to content

Elucidating drug-carrier interactions and release from PCL and PLA microspheres prepared by PES membrane emulsification: a strategy integrating molecular docking.

Sep 2026 · International journal of pharmaceutics · Vol 704, pp. 127419 · 0 citations · 60 references
Medicine

TL;DR

Novel PES membrane emulsification technology is used to investigate the preparation and properties of the PCL and PLA microspheres for sustained drug release and confirmed that microspheres with small and uniform particle size, measured at 40.72 μm, could be achieved using casting solution of 18 wt% prepared PES membrane with additives.

Abstract

PES membrane, with its excellent mechanical properties and biocompatibility, facilitate many pharmaceutical applications, particularly to replace SPG and PVDF membranes for membrane emulsification for microspheres preparation. Despite the extensive use of polycaprolactone (PCL) and polylactic acid (PLA) as drug carriers, their interactions with drug molecules have rarely been directly compared. This knowledge gap directly impacts the rational design and control of drug release rates from microspheres made of these polymers. Hence this study focuses on the use of novel PES membrane emulsification technology to investigate the preparation and properties of the PCL and PLA microspheres for sustained drug release. The effect of additives for casting solutions of membrane were investigated for comparing the size distribution of PCL and PLA microspheres. The encapsulation of three phenolic drug contents (i.e. baicalin, quercetin and bakuchiol) were conducted using PCL and PLA as the carrier of the microspheres. The drug release rate as well as other pharmaceutic characteristics were evaluated, while the molecular action between the drug carriers and drug contents were estimated using molecular docking. The experimental results confirmed that microspheres with small and uniform particle size, measured at 40.72 μm, could be achieved using casting solution of 18 wt% prepared PES membrane with additives. In contrast to the smooth surface of PCL microspheres, their PLA counterparts exhibited a distinctly porous morphology. Molecular docking simulations suggested baicalin exhibit strong binding affinity with PCL and PLA reaching -3.36 kcal/mol and -2.32 kcal/mol, together with its low solubility and molecular size, resulted in slowest release of 0.52% on 17th day when encapsulated in both PCL and PLA microsphere. Bakuchiol exhibited weaker binding affinity with PLA than with PCL, resulting in a higher release rate from PLA microspheres. Quercetin, conversely, showed weaker binding affinity with PCL than with PLA, resulting in a higher release rate from PCL microspheres. Among them, C-Bak microspheres showed the highest 48 h wound closure rate (46.09%), while A-Que microspheres exhibited the best cell viability (287.17%).

View source

Similar papers

Oct 2026

Structural modulation of PCL and PCL–PLGA nanoparticles governs physicochemical properties and drug release kinetics

Abstract The semi-crystalline and hydrophobic nature of poly(ε-caprolactone) (PCL) can limit drug release from polymeric nanoparticles (NPs). Strategies such as PCL amorphization and PCL–poly(lactic-co-glycolic acid) (PLGA) blending modify polymer structural organization, but the extent to which these approaches influe...

Basant Salah Mahmoud, Christopher Mcconville · 0 citations
Open access Sep 2026

Micro-modulation of the intra-structural environment in electrospun drug delivery systems: effects on drug release and hydrolytic degradation.

A multifunctional dual-jet electrospun drug-delivery system designed to accelerate the release of poorly water-soluble bioactive substances by integrating a biodegradable drug carrier with an interlaced, dissolving modifier fraction, allowing the release environment to be modified and drug release to be accelerated wit...

J. Wlodarczyk, Natalia Kurowska, M. Musiał-Kulik et al. · 0 citations
Open access Sep 2026

Biocomposite Microparticles Incorporating Ibuprofen and ZnO Nanoparticles for Controlled Drug Delivery and Antimicrobial Therapy

Preparation of complex biomaterials capable of providing both controlled drug delivery and an increased antimicrobial effect without affecting healthy cells remains a major challenge in pharmaceutical and biomedical applications. This study reports the successful preparation of biocomposite microparticles based on carb...

D. Rață, Gisela Trifas, R. Șomoghi et al. · 0 citations
Oct 2026

Preparation and Drug Release Property of Poly(p-dioxanone) Antibacterial Fiber Coated with Chitosan/Polydopamine.

The adhesion of coating layer, retention of mechanical properties and release control of antibacterial agents have always been the goals and challenges in the preparation of medical sutures. This work constructed a rough and uniform chitosan/polydopamine (CS/PDA) composite coating on biodegradable poly (p-dioxanone) (P...

Wen-Xiang Wang, Xiao-Xuan Xi, Xue-Kai Shen et al. · 0 citations
Open access Sep 2026

Comparative Evaluation of Drug Incorporation and Release Profiles in Six Specific Porous Vaterite CaCO3 Formulations

Background: Vaterite calcium carbonate (CaCO3) particles are promising pH-sensitive carriers for oral drug delivery, but the influence of drug hydrophilicity on loading and release is still not well defined. In this study, we evaluate the encapsulation and release profiles of six specific formulations utilizing metform...

N. Toma, L. Sabri, D. al-Tamimi et al. · 0 citations
Open access Sep 2026

Additive-Mediated Stability Enhancement of Bakuchiol-Loaded Alginate Core–Shell Microcapsules Fabricated by Coaxial Electrospray

The enhanced stability of the PVP-containing formulations was attributed to hydrogen-bonding interactions that reinforced the polymer network, demonstrating an effective strategy for improving the long-term stability of oxidation-sensitive bioactive compounds in cosmetic and pharmaceutical encapsulation systems.

Apisittipong Srinusud, Sukanya Thepwatee, S. Seeyangnok et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.